For Alzheimer’s Scientists, the Amyloid Debate Has No Easy Answers
Science, Spoken - A podcast by WIRED
For years, potential therapies that attack this brain protein have failed to help patients in clinical trials. Now—surprisingly—a new drug shows promise.
